NovaVive Inc. Hires a Senior Vice-President, U.S. Sales & Marketing
NovaVive is pleased to welcome Robert (Bob) Barclay as Senior Vice-President, U.S. Sales & Marketing effective January 1, 2018. Bob has several years of experience in animal health, including 11 years with Zoetis Inc.
NovaVive Signs a Co-Operation Agreement with Hoken Biotechnology to Register and Market Amplimune™ in Asia
NovaVive and Hoken Biotechnology have committed to work together to introduce Amplimune™ to Asian markets. Hoken will conduct clinical studies to support regulatory submissions and will be our sales and marketing agent.
NovaVive Inc. Announces its Canine Cancer Development Plan
Building on its safe and effective treatment for canine mammary cancer (Immunocidin®), NovaVive is targeting canine hemangiosarcoma, chemotherapy-induced neutropenia, and palliation as new indications.
Belleville, Ontario – Graeme McRae, Founder and Chairman Emeritus of Bioniche Life Sciences Inc., has founded NovaVive Inc., a Belleville, Ontario, Canada-based company that is acquiring and developing specialty, imm...